NIBR-6465

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameNIBR-6465

Drug Alias NameNIBR-6465

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionC-C chemokine receptor type 2 antagonistsC-C chemokine receptor type 5 antagonists

TargetsC-C chemokine receptor type 5C-C chemokine receptor type 2

Therapy Area/IndicationsHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesNovartis Pharma Ag

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsHIV Infections

ATC CodeN/A